Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
81 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2024
82 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2024
83 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Asmaa Mohamed Zahran Omar 2024
84 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2024
85 Computed tomography perfusion as a predictor of gastric cancer grades Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2024
86 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
87 Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2023
88 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
89 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023
90 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023